Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible. Innovative approach allows for unprecedented quality in hours rather than ...

Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

Revolutionary gene therapy approaches show promise in treating various retinal conditions, potentially transforming treatment ...

An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

A Connecticut boy is among four children all born with severe childhood blindness who gained “life-changing improvements” to ...

Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...